問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
National Taiwan University Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2023-08-11 - 2023-10-18
Condition/Disease
Test Drug
Participate Sites1Sites
Terminated1Sites
2021-10-30 - 2022-10-18
Participate Sites2Sites
Recruiting2Sites
2022-01-19 - 2027-10-20
Participate Sites9Sites
Not yet recruiting2Sites
Recruiting7Sites
2023-01-10 - 2035-06-15
2018-10-24 - 2024-03-31
Obesity
Semaglutide B 3.0 mg/mL PDS290 or Semaglutide placebo
Participate Sites6Sites
Recruiting4Sites
Terminated2Sites
Division of Cardiovascular Diseases
2019-08-20 - 2022-03-01
Diabetes Mellitus, Type 2
Semaglutide Tablets
Participate Sites4Sites
Terminated4Sites
2019-08-01 - 2022-03-31
type 2 diabetes mellitus
Participate Sites3Sites
Terminated3Sites
2006-09-01 - 2009-06-30
2005-05-01 - 2006-12-31
2008-02-01 - 2009-06-30
全部
